nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Ventricular arrhythmia—Epirubicin—urinary bladder cancer	0.00493	0.00493	CcSEcCtD
Procaine—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00488	0.00489	CcSEcCtD
Procaine—Paralysis—Doxorubicin—urinary bladder cancer	0.00486	0.00486	CcSEcCtD
Procaine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Procaine—Apnoea—Methotrexate—urinary bladder cancer	0.0046	0.0046	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—urinary bladder cancer	0.00456	0.00456	CcSEcCtD
Procaine—Hallucination—Thiotepa—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Procaine—Cardiac arrest—Etoposide—urinary bladder cancer	0.0045	0.0045	CcSEcCtD
Procaine—Diarrhoea—Mitomycin—urinary bladder cancer	0.0044	0.0044	CcSEcCtD
Procaine—Sweating increased—Cisplatin—urinary bladder cancer	0.00434	0.00435	CcSEcCtD
Procaine—Dizziness—Mitomycin—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Procaine—Tinnitus—Thiotepa—urinary bladder cancer	0.00424	0.00425	CcSEcCtD
Procaine—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00418	0.00418	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—urinary bladder cancer	0.00415	0.00416	CcSEcCtD
Procaine—Vasodilation—Epirubicin—urinary bladder cancer	0.00415	0.00416	CcSEcCtD
Procaine—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00411	0.00411	CcSEcCtD
Procaine—Vomiting—Mitomycin—urinary bladder cancer	0.00409	0.00409	CcSEcCtD
Procaine—Chills—Thiotepa—urinary bladder cancer	0.00409	0.00409	CcSEcCtD
Procaine—Rash—Mitomycin—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Procaine—Dermatitis—Mitomycin—urinary bladder cancer	0.00405	0.00405	CcSEcCtD
Procaine—Sweating increased—Etoposide—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Procaine—Erythema—Thiotepa—urinary bladder cancer	0.00396	0.00396	CcSEcCtD
Procaine—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Procaine—Tension—Thiotepa—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Procaine—Nervousness—Thiotepa—urinary bladder cancer	0.00385	0.00385	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Procaine—Nausea—Mitomycin—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Procaine—Vision blurred—Thiotepa—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Procaine—Agitation—Thiotepa—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Procaine—Bradycardia—Cisplatin—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Procaine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Procaine—Leukopenia—Thiotepa—urinary bladder cancer	0.00355	0.00355	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Procaine—Chills—Gemcitabine—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Procaine—Convulsion—Thiotepa—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Procaine—Neuropathy—Epirubicin—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Procaine—Hypertension—Thiotepa—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Procaine—Arthralgia—Thiotepa—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Procaine—Anxiety—Thiotepa—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Procaine—Erythema—Gemcitabine—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Procaine—Tinnitus—Cisplatin—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Procaine—Erythema—Fluorouracil—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Procaine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Procaine—Tachycardia—Thiotepa—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Procaine—Erythema—Cisplatin—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Procaine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.003	0.003	CcSEcCtD
Procaine—Leukopenia—Gemcitabine—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Procaine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Procaine—Chills—Etoposide—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Procaine—Leukopenia—Fluorouracil—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Procaine—Vision blurred—Cisplatin—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Procaine—Tremor—Cisplatin—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Procaine—Hypertension—Gemcitabine—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Procaine—Somnolence—Thiotepa—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Procaine—Convulsion—Fluorouracil—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Procaine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Procaine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Procaine—Fatigue—Thiotepa—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Procaine—Leukopenia—Cisplatin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Procaine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Procaine—Oedema—Gemcitabine—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Procaine—Convulsion—Cisplatin—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Procaine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Procaine—Oedema—Fluorouracil—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Procaine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Procaine—Anxiety—Cisplatin—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Procaine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Procaine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Procaine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Procaine—Urticaria—Thiotepa—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Procaine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Procaine—Leukopenia—Etoposide—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Procaine—Hypotension—Gemcitabine—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Procaine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Procaine—Oedema—Cisplatin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Procaine—Loss of consciousness—Etoposide—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Procaine—Hypotension—Fluorouracil—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Procaine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Procaine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Procaine—Tachycardia—Cisplatin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Procaine—Convulsion—Etoposide—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Procaine—Hypertension—Etoposide—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Procaine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Procaine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Procaine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Procaine—Somnolence—Gemcitabine—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Procaine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Procaine—Somnolence—Fluorouracil—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Procaine—Hypotension—Cisplatin—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Procaine—Fatigue—Gemcitabine—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Procaine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Procaine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Procaine—Pruritus—Thiotepa—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Procaine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00227	0.00228	CcSEcCtD
Procaine—Tachycardia—Etoposide—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Procaine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Procaine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Procaine—Drowsiness—Methotrexate—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Procaine—Hypotension—Etoposide—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Procaine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Procaine—Dizziness—Thiotepa—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Procaine—Urticaria—Fluorouracil—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Procaine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00211	0.00212	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Procaine—Somnolence—Etoposide—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Procaine—Vomiting—Thiotepa—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Procaine—Drowsiness—Epirubicin—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Procaine—Rash—Thiotepa—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Procaine—Dermatitis—Thiotepa—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Procaine—Body temperature increased—Cisplatin—urinary bladder cancer	0.002	0.00201	CcSEcCtD
Procaine—Fatigue—Etoposide—urinary bladder cancer	0.002	0.002	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Procaine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Procaine—Pruritus—Gemcitabine—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Procaine—Nausea—Thiotepa—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Procaine—Pruritus—Fluorouracil—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Procaine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Procaine—Bradycardia—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Procaine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Procaine—Urticaria—Etoposide—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Procaine—Body temperature increased—Etoposide—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Procaine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Procaine—Tinnitus—Methotrexate—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Procaine—Dizziness—Fluorouracil—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Procaine—Chills—Methotrexate—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Procaine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Procaine—Vomiting—Gemcitabine—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Procaine—Rash—Gemcitabine—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Procaine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Procaine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Procaine—Tinnitus—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Procaine—Erythema—Methotrexate—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Procaine—Vomiting—Fluorouracil—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Procaine—Rash—Fluorouracil—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Procaine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Procaine—Chills—Epirubicin—urinary bladder cancer	0.00164	0.00165	CcSEcCtD
Procaine—Pruritus—Etoposide—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Procaine—Nausea—Gemcitabine—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Procaine—Vomiting—Cisplatin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Procaine—Vision blurred—Methotrexate—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Procaine—Rash—Cisplatin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Procaine—Dermatitis—Cisplatin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Procaine—Erythema—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Procaine—Diarrhoea—Etoposide—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Procaine—Nausea—Fluorouracil—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Procaine—Tension—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Procaine—Nervousness—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Procaine—Dizziness—Etoposide—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Procaine—Leukopenia—Methotrexate—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Procaine—Chills—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Procaine—Nausea—Cisplatin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Procaine—Vision blurred—Epirubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Procaine—Convulsion—Methotrexate—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Procaine—Vomiting—Etoposide—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Procaine—Erythema—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Procaine—Agitation—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Procaine—Rash—Etoposide—urinary bladder cancer	0.00146	0.00147	CcSEcCtD
Procaine—Dermatitis—Etoposide—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Procaine—Arthralgia—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Procaine—Tension—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Procaine—Nervousness—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Procaine—Syncope—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Procaine—Leukopenia—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Procaine—Convulsion—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Procaine—Nausea—Etoposide—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Procaine—Hypertension—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Procaine—Arthralgia—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Procaine—Agitation—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Procaine—Anxiety—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Procaine—Syncope—Doxorubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Procaine—Oedema—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Procaine—Hypotension—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Procaine—Shock—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Procaine—Convulsion—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Procaine—Hypertension—Doxorubicin—urinary bladder cancer	0.00127	0.00128	CcSEcCtD
Procaine—Tachycardia—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Procaine—Anxiety—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Procaine—Somnolence—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Procaine—Hypotension—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Procaine—Oedema—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Procaine—Fatigue—Methotrexate—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Procaine—Shock—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00116	0.00117	CcSEcCtD
Procaine—Somnolence—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Procaine—Hypotension—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Procaine—Fatigue—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Procaine—Urticaria—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Procaine—Somnolence—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Procaine—Fatigue—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Procaine—Urticaria—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Procaine—Pruritus—Methotrexate—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00096	0.00096	CcSEcCtD
Procaine—Urticaria—Doxorubicin—urinary bladder cancer	0.000957	0.000958	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Procaine—Pruritus—Epirubicin—urinary bladder cancer	0.000921	0.000922	CcSEcCtD
Procaine—Dizziness—Methotrexate—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Procaine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000891	0.000891	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000888	0.000888	CcSEcCtD
Procaine—Vomiting—Methotrexate—urinary bladder cancer	0.000885	0.000885	CcSEcCtD
Procaine—Rash—Methotrexate—urinary bladder cancer	0.000878	0.000878	CcSEcCtD
Procaine—Dermatitis—Methotrexate—urinary bladder cancer	0.000877	0.000877	CcSEcCtD
Procaine—Dizziness—Epirubicin—urinary bladder cancer	0.000861	0.000861	CcSEcCtD
Procaine—Pruritus—Doxorubicin—urinary bladder cancer	0.000853	0.000853	CcSEcCtD
Procaine—Vomiting—Epirubicin—urinary bladder cancer	0.000828	0.000828	CcSEcCtD
Procaine—Nausea—Methotrexate—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000825	0.000825	CcSEcCtD
Procaine—Rash—Epirubicin—urinary bladder cancer	0.000821	0.000821	CcSEcCtD
Procaine—Dermatitis—Epirubicin—urinary bladder cancer	0.00082	0.000821	CcSEcCtD
Procaine—Dizziness—Doxorubicin—urinary bladder cancer	0.000797	0.000797	CcSEcCtD
Procaine—Nausea—Epirubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Procaine—Vomiting—Doxorubicin—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Procaine—Rash—Doxorubicin—urinary bladder cancer	0.00076	0.00076	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000759	0.000759	CcSEcCtD
Procaine—Nausea—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Procaine—Clomifene—ESR1—urinary bladder cancer	0.00019	1	CrCbGaD
